The largest randomized trial in asymptomatic patients with smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.
from Latest Science News -- ScienceDaily https://ift.tt/2JofueP
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment